Here are relevant reports on : regenerative-medicine-market
-
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping) Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Personalized Medicine (Biochips, SNP Genotyping)-Competitive Analysis Market - 2019 By Types, Application & Geography
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Regenerative Agriculture Market by Practice (Aquaculture, Agroecology, Agroforestry, Biochar & Terra Preta, Holistically Managed Grazing, No-Till & Pasture Cropping, Silvopasture), Application and Region - Global Forecast to 2027
The regenerative agriculture market is experiencing an exceptional period of growth, with a projected increase from US$ 8.7 billion in 2022 to an incredible US$ 16.8 billion by 2027. Key players in this market include Nestle SA (Switzerland), Danone SA (France), General Mills, Inc (US), Cargill Incorporated (US), Unilever PLC (United Kingdom), Grounded (South Africa), Soil Capital Belgium SPRL (Belgium), Indigo Ag, Inc (US), and Serenity Kids (US).
- Published: December 2022
- Price: $ 4950
- TOC Available:
-
Sustainable Agriculture Market by Type (Organic Farming, Agroecology, Regenerative Agriculture, Conservation Agriculture, and Precision Agriculture), Application (Food Production, Bioenergy, Environmental Services, and Water Management), and Region - Global Forecast to 2029
The global market for sustainable agriculture, estimated to be US$ XX.X billion by 2024, has an impressive growth forecast, with growth expected to reach $XXX.X billion by 2029 at a compound annual growth rate (CAGR) of 6.1%. that is, within the forecast period. The key players in this market include Organic Valley (US), Nature's Path Foods (US), Eden Foods, Inc. (US), Deere & Company (US), Trimble Inc. (US), AGCO Corporation (US), AgJunction LLC (US), Raven Industries, Inc. (US), AG Leader Technology (US), Teejet Technologies (US), Topcon (US), Taranis (Israel), and others
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Automotive Ultra-Capacitor Market by Power Modules (volts), Application (Start-Stop Application, Regenerative Braking System, Active Suspension), Components, by Transport mode, Electric Vehicle, by Region - Global Forecast to 2025
Ultra-capacitors are electrical energy storage devices. Ultra-capacitors are used in buses, trucks, trains, and other vehicles. The electric vehicle is one of the major areas where the application of ultra-capacitors is expected to grow at a rapid pace. Government subsidies and incentives have provided the manufacturers the required impetus to promote electric vehicles. Ultra-Capacitors in electric vehicles have a high potential in the automotive industry; however, their development requires continuous collaboration between vehicle manufacturers and battery manufacturers.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Cryocooler Market by Type (GM, PT, JT, Stirling, Brayton), Offering (Hardware, Services), Heat Exchanger (Recuperative, Regenerative) Operating Cycle (Open,Closed loop), Application, and Geography - Global Forecast
The Cryocooler Market Size is expected to grow from USD 2.3 billion in 2020 to USD 3.1 billion by 2025, at a CAGR of 6% during the forecast period. The report profiles key players such as Sumitomo Heavy Industries (Japan), Chart Industries (US), Sunpower (US), Cryomech (US), Northrop Grumman Corporation (US), Advanced Research Systems (US), DH Industries (The Netherlands), Janis Research Company (US), RICOR – Cryogenic & Vacuum Systems (Israel), Superconductor Technologies (US), and Air Liquide (France).
- Published: October 2020
- Price: $ 4950
- TOC Available:
-
Fluorometer Market by Light source (Lamps, LEDs, Diode Lasers, and Lasers), Application (Chemistry/Biochemistry, Medicine & Others), and End User (Hospitals, Pharmaceutical and Biotechnology Firms & CROs, Others) - Global Forecast to 2023
The global Fluorometer market is expected to reach USD 668.2 million by 2023 from USD 521.1 million in 2018, growing at a CAGR of 5.1%. Increasing incidence of cancer, advancement in cancer diagnostics, technological advancement in fluorometry are some of the major factors driving the growth of the global fluorometer market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Precision Medicine Software Market by Delivery Mode (On-Premise & Cloud-Based), End User (Healthcare Providers, Research Centers & Government Institutes, Pharmaceutical & Biotechnology Companies), Application, and Region - Global Forecast to 2024
The precision medicine software market is projected to reach USD 2.0 billion by 2024, at a CAGR of 11.5%. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. However, the high cost of deployment, issues related to the secure storage of large volumes of sequenced data, lack of reimbursement for precision medicine-based treatments, and the dearth of skilled IT professionals in healthcare are expected to restrain market growth to a certain extent in the coming years. Syapse, Inc. (US), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (US), Fabric Genomics (US), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (US), N-of-One, Inc. (US), Human Longevity, Inc. (US), Translational Software, Inc. (US), Sunquest Information Systems Inc. (US), Gene42, Inc. (Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands)
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), hybrid PET, & Planar Scintigraphy), Application (Cardiology, Oncology & Neurology) & by End user (Hospitals, Imaging Centers) - Global Forecasts to 2020
Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis. The nuclear medicine equipment market is expected to grow at a single-digit CAGR in the next five years. This market is poised to reach USD 2.13 Billion by 2020 from USD 1.78 Billion in 2015, at a CAGR of 3.6% during the forecast period.
- Published: September 2015
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
